Name: ASPPH 2024 Annual Meeting
Start: 2024-03-21T00:00:00-04:00
End: 2024-03-23T23:59:59-04:00

Industry News

Biodefense Headlines – 30 November 2023

News Scan November 30, 2023

News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

Inflammatix Completes Development for Acute Infection and Sepsis Test System

NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox

Industry News

Novavax’s Prototype COVID-19 Vaccine Nuvaxovid Receives Full Approval in Singapore

Strengthening Clinical Research Response to Outbreaks and Pandemics

Molecular Diagnostic Test for Six Biothreat Pathogens Receives FDA Clearance

Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus

Regeneron Awarded $325M for Development of Next-Gen COVID-19 Monoclonal Antibody Therapy

BARDA Funds Development of Patch-Based Ebola Diagnostic

RedHill Biopharma Highlights Federal Medical Countermeasure Investments

Airborne Biothreat Security Startup Raises $5.4M

BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection

Cue Health Awarded $28M to Develop Multiplex Respiratory Test

BD Respiratory Viral Panel Receives FDA-Clearance

BD Gets FDA Clearance for Influenza, RSV, COVID-19 Respiratory Viral Panel

908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection

U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions

After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure

Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX

VitriVax Wins DoD Contract to Develop Single-Shot Vaccine for Melioidosis and Glanders

DARPA Award to Ginkgo Bioworks Aims to Revolutionize Speed of Medical Countermeasure Manufacturing

Revive Therapeutics Announces Results of Phase 3 Study for Bucillamine in the Treatment of COVID-19

FebriDx Rapid Diagnostic Receives FDA Clearance

Biodefense Headlines – 30 November 2023

AMR One Health Priority Research Agenda: Transmission

2024 Fungal Genetics Conference

ASPPH 2024 Annual Meeting